Association of kidney function with cancer incidence and its influence on cancer risk of smoking: The Japan Multi-Institutional Collaborative Cohort Study.
CKD
J-MICC
interaction
neoplasms
onco-nephrology
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
15 08 2023
15 08 2023
Historique:
revised:
27
03
2023
received:
12
01
2023
accepted:
11
04
2023
medline:
21
6
2023
pubmed:
9
5
2023
entrez:
9
5
2023
Statut:
ppublish
Résumé
The association between kidney function and cancer incidence is inconsistent among previous reports, and data on the Japanese population are lacking. It is unknown whether kidney function modifies the cancer risk of other factors. We aimed to evaluate the association of estimated glomerular filtration rate (eGFR) with cancer incidence and mortality in 55 242 participants (median age, 57 years; 55% women) from the Japan Multi-Institutional Collaborative Cohort Study. We also investigated differences in cancer risk factors between individuals with and without kidney dysfunction. During a median 9.3-year follow-up period, 4278 (7.7%) subjects developed cancer. Moderately low and high eGFRs were associated with higher cancer incidence; compared with eGFR of 60-74 ml/min/1.73 m
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
732-741Informations de copyright
© 2023 UICC.
Références
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395:709-733.
Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease: a systematic review and meta-analysis. PLoS One. 2016;11:e0158765.
Vajdic CM, McDonald SP, McCredie MRE, et al. Cancer incidence before and after kidney transplantation. JAMA. 2006;296:2823-2831.
Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004;140:9-18.
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-867.
Stewart JH, Vajdic CM, Van Leeuwen MT, et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant. 2009;24:3225-3231.
Shang W, Huang L, Li L, et al. Cancer risk in patients receiving renal replacement therapy: a meta-analysis of cohort studies. Mol Clin Oncol. 2016;5:315-325.
Chien CC, Han MM, Chiu YH, et al. Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan. J Cancer. 2017;8:9-18.
Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet. 1999;354:93-99.
Wong G, Staplin N, Emberson J, et al. Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer. 2016;16:488.
Wong G, Hayward JS, McArthur E, et al. Patterns and predictors of screening for breast and cervical cancer in women with CKD. Clin J Am Soc Nephrol. 2017;12:95-104.
Chen X, Li Y, Ding X, et al. Incidence, risk, and prognosis of cancer in patients on chronic hemodialysis. Blood Purif. 2020;49:310-321.
Wong G, Hayen A, Chapman JR, et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol. 2009;20:1341-1350.
Christensson A, Savage C, Sjoberg DD, et al. Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years. Int J Cancer. 2013;133:1452-1458.
Lowrance WT, Ordoñez J, Udaltsova N, Russo P, Go AS. CKD and the risk of incident cancer. J Am Soc Nephrol. 2014;25:2327-2334.
Mok Y, Matsushita K, Ballew SH, et al. Kidney function, proteinuria, and cancer incidence: the Korean heart study. Am J Kidney Dis. 2017;70:512-521.
Tu H, Wen CP, Tsai SP, et al. Cancer risk associated with chronic diseases and disease markers: prospective cohort study. BMJ. 2018;360:k134.
Xu H, Matsushita K, Su G, et al. Estimated glomerular filtration rate and the risk of cancer. Clin J Am Soc Nephrol. 2019;14:530-539.
Park S, Lee S, Kim Y, et al. Risk of cancer in pre-dialysis chronic kidney disease: a nationwide population-based study with a matched control group. Kidney Res Clin Pract. 2019;38:60-70.
Kitchlu A, Reid J, Jeyakumar N, et al. Cancer risk and mortality in patients with kidney disease: a population-based cohort study. Am J Kidney Dis. 2022;80:436-448.e1.
Miyamoto Y, Katagiri R, Yamaji T, et al. Association of chronic kidney disease with total and site-specific cancer incidence in participants of the Japan public health center-based prospective study. Nephrol Dial Transplant. 2022. doi:10.1093/ndt/gfac288.
Hamajima N, J-MICC Study Group. The Japan multi-institutional collaborative cohort study (J-MICC study) to detect gene-environment interactions for cancer. Asian Pacific J Cancer Prev. 2007;8:317-323.
Takeuchi K, Naito M, Kawai S, et al. Study profile of the Japan multi-institutional collaborative cohort (J-MICC) study. J Epidemiol. 2021;31:660-668.
Watanabe Y, Yamagata K, Nishi S, et al. Japanese Society for Dialysis Therapy Clinical Guideline for “hemodialysis initiation for maintenance hemodialysis”. Ther Apher Dial. 2015;19:93-107.
Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-992.
Au EH, Wong G, Howard K, et al. Factors associated with advanced colorectal neoplasia in patients with CKD. Am J Kidney Dis. 2022;79:549-560.
Bernaards CM, Twisk JWR, Snel J, Van Mechelen W, Kemper HCG. Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years. Addiction. 2001;96:1653-1661.
Ando Y, Minami H, Saka H, Ando M, Sakai S, Shimokata K. Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing. Br J Cancer. 1997;76:1067-1071.
Royston P, Sauerbrei W. Interaction of treatment with a continuous variable: simulation study of significance level for several methods of analysis. Stat Med. 2013;32:3788-3803.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
Jørgensen L, Heuch I, Jenssen T, Jacobsen BK. Association of albuminuria and cancer incidence. J Am Soc Nephrol. 2008;19:992-998.
Oh HJ, Lee HA, Moon CM, Ryu DR. Incidence risk of various types of digestive cancers in patients with pre-dialytic chronic kidney disease: a nationwide population-based cohort study. PLoS One. 2018;13:1-12.
Rundle A. Carcinogen-DNA adducts as a biomarker for cancer risk. Mutat Res. 2006;600:23-36.
Khariwala SS, Hatsukami D, Hecht SS. Tobacco carcinogen metabolites and DNA adducts as biomarkers in head and neck cancer: potential screening tools and prognostic indicators. Head Neck. 2012;34:441-447.
Madsen AM, Rundle AG, Mooney LA, Tang D, Perera FP. Effect of kidney function on benzo [a] pyrene-DNA adducts in WBC of smokers. Cancer Res. 2005;65:525.
United States Department of Health and Human Services. The health consequences of smoking: 50 years of progress-a report of the surgeon general. Rep Surg Gen. 2014. https://www.ncbi.nlm.nih.gov/books/NBK179276/. Accessed May 2, 2023.
Malachi T, Zevin D, Gafter U, Chagnac A, Slor H, Levi J. DNA repair and recovery of RNA synthesis in uremic patients. Kidney Int. 1993;44:385-389.
Tamura K, Utsunomiya J, Iwama T, et al. Mechanism of carcinogenesis in familial tumors. Int J Clin Oncol. 2004;9:232-245.
Launay-Vacher V. Epidemiology of chronic kidney disease in cancer patients: lessons from the IRMA study group. Semin Nephrol. 2010;30:548-556.
Weng PH, Hung KY, Huang HL, Chen JH, Sung PK, Huang KC. Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol. 2011;6:1121-1128.
Iff S, Craig JC, Turner R, et al. Reduced estimated GFR and cancer mortality. Am J Kidney Dis. 2014;63:23-30.
Wakasugi M, Narita I, Iseki K, et al. The effect of CKD on associations between lifestyle factors and all-cause, cancer, and cardiovascular mortality: a population-based cohort study. Intern Med. 2021;60:2189-2200.
Berrington de González A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 2004;363:345-351.